Hematology TimesFDA approves maintenance therapy for CLLJanuary 20, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesDrug approved to treat ALL in EUJanuary 20, 2016Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL
Hematology NewsOfatumumab approved for extended treatment of CLL patients in complete or partial responseJanuary 19, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology TimesCIPN persists in female cancer survivorsJanuary 19, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesCancer survival tied to reduction in treatmentJanuary 15, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLHodgkin Lymphoma
Hematology TimesPredicting transformation from MDS to AMLJanuary 14, 2016AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology NewsVenetoclax gets 79% overall response rate in high-risk CLLJanuary 13, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsIbrutinib response durable at 1 year in CLL patients who relapsed after allogeneic stem cell transplantsJanuary 13, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology TimesDrug gets priority review as CLL treatmentJanuary 13, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesTeam identifies new mechanism of megakaryocyte differentiationJanuary 13, 2016Leukemia, Myelodysplasia, Transplantation
Hematology TimesGenes may be targets for AML therapyJanuary 12, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesForces driving leukemia differ in kids and adultsJanuary 12, 2016Leukemia, Myelodysplasia, TransplantationPediatrics
Hematology TimesHSPCs shape their own environment, team saysJanuary 9, 2016AnemiaLeukemia, Myelodysplasia, TransplantationTransplantation
Hematology TimesUS cancer stats: The good and the badJanuary 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatrics
Hematology TimesIncreasing eligibility for engineered T-cell therapyJanuary 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin Lymphoma
